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Background: Data for long-term outcomes of stenting versus coronary-artery bypass grafting (CABG) for nonbifurcation lesion of unprotected left 
main coronary artery (LMCA) disease are limited. We evaluate long-term clinical outcomes after stenting versus CABG for ostial and shaft lesion of 
unprotected LMCA disease.
Methods: A total of 1083 consecutive patients with ostial and/or shaft of unprotected LMCA stenosis who underwent stenting (n=557) or CABG 
(n=526) were examined. The 5-year adverse outcomes (death; a composite outcome of death, Q-wave myocardial infarction [MI], or stroke; and 
target-vessel revascularization [TVR]) were compared with the use of univariate and multivariate analysis.
Results: During follow-up of median 5 years, after adjustment of baseline covariates, the risk of death (hazard ratio [HR], 0.982, 95% confidence 
interval [CI], 0.773-1.248, p=0.885), and the composite of death, Q-wave MI, or stroke (HR, 0.959, 95% CI, 0.757-1.214, p=0.726) were not 
significantly different between stenting and CABG. However, the adjusted risk of TVR was significantly higher in stenting group than in CABG group 
(HR, 3.694, 95% CI, 2.224-6.136, p<0.001) (Table). Similar results were in comparisons of DES or BMS with concurrent CABG.
Conclusions: During 5-year follow-up, stenting showed similar rates of mortality and of the composite of death, Q-wave MI, or stroke, but higher 
rates of TVR as compared with CABG for patients with unprotected ostial and shaft LMCA lesions.
